menu
    • menu

    Company profile for Minerva Neurosciences

    NEW Drugs in Dev: 3
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of a portfolio of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options. Leveraging extensive domain expertise, we have identified and acquired or in-licensed a portfolio of development-stage proprietary compounds with w...
    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of a portfolio of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options. Leveraging extensive domain expertise, we have identified and acquired or in-licensed a portfolio of development-stage proprietary compounds with what we believe are innovative mechanisms of action. Our executive management team includes globally recognized specialists in central nervous system diseases addressing significant unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Minerva NeurosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1601 Trapelo Road, Suite 286 Waltham, MA 02451
    Telephone
    Telephone
    617-600-7373
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.minervaneurosciences.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/minerva-neurosciences
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Minerva Neurosciences Reports Q1 2026 Financials And Business
    Minerva Neurosciences Reports Q1 2026 Financials And Business

    05 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/05/3287601/32445/en/minerva-neurosciences-provides-first-quarter-2026-financial-results-and-business-updates.html

    GLOBENEWSWIRE
    05 May 2026
    Share Share
    Minerva Announces Leadership Transition
    Minerva Announces Leadership Transition

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267830/32445/en/Minerva-Announces-Leadership-Transition.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Minerva Neurosciences Launches Global Phase 3 Roluperidone Trial
    Minerva Neurosciences Launches Global Phase 3 Roluperidone Trial

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3266016/32445/en/Minerva-Neurosciences-Announces-First-Patient-Screened-in-Global-Phase-3-Confirmatory-Trial-of-Roluperidone-for-the-Treatment-of-Negative-Symptoms-of-Schizophrenia.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Minerva Neurosciences Reveals Roluperidone-Olanzapine Safety
    Minerva Neurosciences Reveals Roluperidone-Olanzapine Safety

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262573/32445/en/Minerva-Neurosciences-Presents-Data-from-its-Open-label-Safety-Trial-Evaluating-Roluperidone-Co-administered-with-Olanzapine-at-SIRS-2026.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Minerva Neurosciences Joins Stifel 2026 Virtual CNS Forum
    Minerva Neurosciences Joins Stifel 2026 Virtual CNS Forum

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254445/32445/en/Minerva-Neurosciences-to-Participate-in-The-Stifel-2026-Virtual-CNS-Forum.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Minerva Neurosciences Reveals Q4 And FY2025 Financial Result
    Minerva Neurosciences Reveals Q4 And FY2025 Financial Result

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253620/32445/en/Minerva-Neurosciences-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results-and-Business-Updates.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search